Ventracor Limited Announces FY2007 Results And Strong Revenue Growth on 64 LVAD Implants

Sydney, Aug 16, 2007 (ACN Newswire) - Ventracor (ASX: VCR)(ADR: VTCRY) today announced its results for the year ending 30 June 2007, with increasing sales revenues in the US, Europe and Australasia of $4.9m (2006;$1.1m) from 64 implants, and a net loss of $36.5m (2006;$30m).
MORE ON THIS TOPIC